{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-026026","form_type":"8-K","ticker":"BACK","cik":"0001729944","company_name":"IMAC Holdings, Inc.","filed_at":"2024-07-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.338528+00:00","generated_at":"2026-05-31T23:47:47.210669+00:00","sec_items":["4.01","5.02","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"IMAC Holdings appoints new auditor Marcum, expands board to five with two new directors","bullets":["On June 26, 2024, terminated Salberg & Company as auditor and engaged Marcum LLP; no disagreements reported.","Board increased to 5 members; Dr. Peter Beitsch and Dr. Matthew Schwartz appointed as directors effective June 26, 2024.","Dr. Beitsch is a surgical oncologist with focus on breast cancer and melanoma; co-founder of Targeted Medical Education.","Dr. Schwartz is a radiation oncologist with 20 years experience; co-founded Las Vegas Cyberknife; serves on Board of Managers.","Salberg's FY2023 audit report contained going-concern explanatory paragraph; no adverse opinions."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-026026","json":"https://secwatch.observer/filing/0001493152-24-026026.json","markdown":"https://secwatch.observer/filing/0001493152-24-026026.md","text":"https://secwatch.observer/filing/0001493152-24-026026.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1729944/000149315224026026/0001493152-24-026026-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1729944/000149315224026026/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T23:47:47.210669+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1ced460efd","claim":"Peter Beitsch was appointed as Director at IMAC Holdings, Inc..","evidence_excerpt":"Peter Beitsch, MD, and Matthew Schwartz, MD joined the Board, effective June 26, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1729944/000149315224026026/0001493152-24-026026-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"6834e5d1bf","claim":"Matthew Schwartz was appointed as Director at IMAC Holdings, Inc..","evidence_excerpt":"Peter Beitsch, MD, and Matthew Schwartz, MD joined the Board, effective June 26, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1729944/000149315224026026/0001493152-24-026026-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}